Dow Up0.76% Nasdaq Up0.69%

Peregrine Pharmaceuticals, Inc. (PPHM)

-NasdaqCM
1.51 Up 0.04(2.72%) Oct 24, 4:00PM EDT
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Oct 14
Next Qtr.
Jan 15
Current Year
Apr 15
Next Year
Apr 16
Avg. Estimate-0.07-0.08-0.30-0.37
No. of Analysts3.003.003.003.00
Low Estimate-0.08-0.09-0.34-0.40
High Estimate-0.06-0.06-0.26-0.32
Year Ago EPS-0.05-0.06-0.22-0.30
Revenue EstCurrent Qtr.
Oct 14
Next Qtr.
Jan 15
Current Year
Apr 15
Next Year
Apr 16
Avg. Estimate5.82M5.70M22.75M21.75M
No. of Analysts2222
Low Estimate5.64M5.39M22.00M19.50M
High Estimate6.00M6.00M23.50M24.00M
Year Ago Sales7.35M3.88M22.40M22.75M
Sales Growth (year/est)-20.90%46.70%1.60%-4.40%
Earnings HistoryOct 13Jan 14Apr 14Jul 14
EPS Est-0.05-0.06-0.07-0.06
EPS Actual-0.05-0.06-0.06-0.08
Difference0.000.000.01-0.02
Surprise %0.00%0.00%14.30%-33.30%
EPS TrendsCurrent Qtr.
Oct 14
Next Qtr.
Jan 15
Current Year
Apr 15
Next Year
Apr 16
Current Estimate-0.07-0.08-0.30-0.37
7 Days Ago-0.07-0.08-0.30-0.37
30 Days Ago-0.07-0.08-0.30-0.35
60 Days Ago-0.07-0.07-0.27-0.32
90 Days Ago-0.07-0.07-0.27-0.32
EPS RevisionsCurrent Qtr.
Oct 14
Next Qtr.
Jan 15
Current Year
Apr 15
Next Year
Apr 16
Up Last 7 Days0000
Up Last 30 Days0000
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstPPHMIndustrySectorS&P 500
Current Qtr.-40.00%N/A-78.80%15.30%
Next Qtr.-33.30%N/A-49.50%22.10%
This Year-36.40%N/A47.00%7.50%
Next Year-23.30%N/A36.30%11.70%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A22.06%15.98%10.06%
Price/Earnings (avg. for comparison categories)-4.906.227.1615.57
PEG Ratio (avg. for comparison categories)N/A21.536.231.84
Currency in USD.